Established in 2015, PROTEINA Co., Ltd. is a South Korean biotechnology company specializing in the analysis of protein-protein interactions (PPIs) to advance disease diagnosis and drug discovery. The company has developed a proprietary platform that enables quantitative measurement of PPIs at the single-molecule level, facilitating the identification of novel biomarkers and therapeutic targets. ​

Single-Molecule Co-Immunoprecipitation (SMCIP) Technology: This innovative platform allows for the precise quantification of PPIs, providing highly reproducible bioinformatic data. The technology supports the integration of datasets collected from various locations and time points, accelerating the discovery of new biomarkers and the development of targeted therapies.

Private

Biotech